Table 3. ADCC and CMC assays detecting anti-CD20 antibody activity in RRCL and RSCL.

Cell Line	% ADCC (N=3)					% CMC (N=4)
	R	Ofatumumab	TG20	R603	GA101	R	Ofatumumab	TG20	R603	GA101
Raji	25.99	30.82	47.9	53.57	58	79.87	87	82.05	80.08	12.87
Raji2R	14.35	14.63	26.84	29.78	39.41	3.26	8.68	4.6	1.94	0.89
Raji4RH	7.03	6.88	13.2	15.36	23.56	3.62	9.42	4.4	3.72	2.45
RL	22.62	25.9	45.65	52.1	56.45	89.52	91.28	88.86	88.94	13.98
RL4RH	17.07	17.88	29.72	32.78	42.07	4.54	9.07	7.11	4.64	3.77